Travere Therapeutics (TVTX) Q3 2026 Earnings

4AugConfirmed
Q3 2025
Q4 2025
Q2 2026
Q3 2026
-0.4
-0.17
0.05
0.28

Details

Expected EPS
-0.134655
Actual EPS
-0.37
Surprise EPS
-0.24
Surprise Percent
+174.78%

Description

Travere Therapeutics (TVTX) has reported earnings of -0.37 per share for Q3 2026.

0 Comments

Share your thoughts